Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
4.870
+0.030 (0.62%)
At close: Nov 28, 2025, 1:00 PM EST
5.00
+0.13 (2.67%)
After-hours: Nov 28, 2025, 4:53 PM EST
Achieve Life Sciences Employees
Achieve Life Sciences had 25 employees as of December 31, 2024. The number of employees increased by 3 or 13.64% compared to the previous year.
Employees
25
Change (1Y)
3
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$2,093,840
Market Cap
259.25M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25 | 3 | 13.64% |
| Dec 31, 2023 | 22 | 2 | 10.00% |
| Dec 31, 2022 | 20 | 4 | 25.00% |
| Dec 31, 2021 | 16 | 3 | 23.08% |
| Dec 31, 2020 | 13 | -1 | -7.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ACHV News
- 23 days ago - Achieve Life Sciences, Inc. (ACHV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program - GlobeNewsWire
- 26 days ago - Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation - GlobeNewsWire
- 4 weeks ago - Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025 - GlobeNewsWire
- 5 weeks ago - Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer - GlobeNewsWire
- 5 weeks ago - Achieve: Expedited Review Of Cytisinicline Sets The Stage For Development Expansion - Seeking Alpha
- 6 weeks ago - Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation - GlobeNewsWire
- 2 months ago - Achieve Life Sciences Announces Granting of New Hire Inducement Awards - GlobeNewsWire